The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrolChun‐Jung Cho(National Defense Medical Center), Dah‐Shyong Yü(Tri-Service General Hospital)Oncology LettersOctober 30, 201910.3892/ol.2019.11023Cited by 37SaveCiteExport RISWatch citationsRelated PapersExosome-Derived LINC00960 and LINC02470 Promote the Epithelial-Mesenchymal Transition and Aggressiveness of Bladder Cancer Cells|Cells|2020|68Long Noncoding RNA LINC02470 Sponges MicroRNA-143-3p and Enhances SMAD3-Mediated Epithelial-to-Mesenchymal Transition to Promote the Aggressive Properties of Bladder Cancer|Cancers|2022|20Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters|Cancers|2021|16